Investing Profile
Rachel Lane
Your Intro Paths to Rachel Lane
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Rachel is a member of
Stromedix Inc. Network
267 CONNECTIONS
Stromedix Inc. Network
267 CONNECTIONS
Stromedix Inc. Network
267 CONNECTIONS
Stromedix Inc. Network
267 CONNECTIONS
Stromedix Inc. Network
267 CONNECTIONS
Current Investing Position
Versant Ventures Principal
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Current Fund Size
$102.2M
Rachel Lane is on these Sector & Stage Rankings
Rachel Lane's Media (1)
Rachel Lane's Experience
Postdoctoral Fellow Stromedix Inc.Present
Analyst (intern) Ascent Biomedical VenturesPresent
Consultant Ascent Biomedical VenturesPresent
Assistant Director, Scientific Affairs Alzheimer's Drug Discovery FoundationPresent
Associate Director, Scientific Affairs Alzheimer's Drug Discovery FoundationPresent
Equity Research, Biotechnology Stromedix Inc.Present
Lead, Portfolio Strategy and New Product Commercialization Ovid TherapeuticsPresent
Director, Business Development Calico Life SciencesPresent
Principal Versant VenturesPresent
Board Observer iECURE, inc.Present
Board Observer Santa Ana Bio, Inc.Present
Board Observer Stromedix Inc.Present
Interim Chief Business Officer Belharra TherapeuticsPresent
Chief Business Officer Inception TherapeuticsPresent
Board Observer Kate TherapeuticsPresent
Interim Chief Business Officer Stromedix Inc.Present
Board Member Stromedix Inc.Present
Chief Business Officer Belharra TherapeuticsPresent
Rachel Lane's Education
Sheffield Hallam University BSc (Hons) Biomedical Sciences
The University of Sheffield Ph.D. Molecular and Cell Biology
Investors who invest with Rachel Lane
Sign in with Google →Scouts & Angels Affiliated With Rachel Lane
Sign in with Google →